SCHEMBL3482401

SCHEMBL3482401

CCc1ccc([Si](O)(O)O)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LPL P06858 1/20 0.46
LIPG Q9Y5X9 1/20 0.46
ALDH1A1 P00352 2/20 0.44
TP53 P04637 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
TAAR1 Q96RJ0 1/20 0.42
PLAU P00749 1/20 0.41
CYP2A6 P11509 1/20 0.41
TRPA1 O75762 1/20 0.41
IDO1 P14902 2/20 0.40
PLK1 P53350 1/20 0.40
EGFR P00533 1/20 0.39
RAB9A P51151 1/20 0.38
MAPK1 P28482 2/20 0.38
L3MBTL1 Q9Y468 2/20 0.38
CA2 P00918 1/20 0.38
TSHR P16473 1/20 0.38
ATM Q13315 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
CYP2C9 P11712 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1686679 0.84 CYP2A6 (0.46) LPLLIPGALDH1A1TP53SMN1; SMN2
SCHEMBL3482405 0.82 LPL (0.44) LPLLIPGALDH1A1TP53SMN1; SMN2
SCHEMBL3482037 0.82 LPL (0.44) LPLLIPGALDH1A1TP53SMN1; SMN2
SCHEMBL14579977 0.78 TP53 (0.48) LPLLIPGALDH1A1TP53SMN1; SMN2
SCHEMBL3482305 0.77 TP53 (0.54) LPLLIPGALDH1A1TP53SMN1; SMN2
SCHEMBL3482629 0.77 TP53 (0.54) LPLLIPGALDH1A1TP53SMN1; SMN2
Methyl Alcohol SCHEMBL27728601 0.76 LPL (0.60) LPLLIPGALDH1A1TP53SMN1; SMN2
SCHEMBL272403 0.76 ESR1 (0.30)
SCHEMBL36295 0.76 TP53 (0.67) LPLLIPGALDH1A1TP53SMN1; SMN2
SCHEMBL8306401 0.76 TP53 (0.46) LPLLIPGALDH1A1TP53SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2128897-B1 SILICON DIELECTRIC TREATING AGENT FOR USE AFTER ETCHING, PROCESS FOR PRODUCING SEMICONDUCTOR DEVICE, AND SEMICONDUCTOR DEVICE FUJITSU LTD (JP) 2015-05-06 EP disclosed
US-8871877-B2 Hybrid organic-inorganic materials that contain stabilized carbene UNIVERSITE CLAUDE BERNARD LYON 1 (UCBL) (FR) 2014-10-28 US disclosed
US-8716209-B2 Agent for post-etch treatment of silicon dielectric film, method of manufacturing semiconductor device, and semiconductor device FUJITSU LIMITED (JP) 2014-05-06 US disclosed
US-7964878-B2 Light emitting polymer devices using self-assembled monolayer structures HCF PARTNERS, LP (US) 2011-06-21 US disclosed
US-20100134052-A1 Light Emitting Polymer Devices Using Self-Assembled Monolayer Structures HCF PARTNERS, L.P. (US) 2010-06-03 US disclosed
US-20100007031-A1 AGENT FOR POST-ETCH TREATMENT OF SILICON DIELECTRIC FILM, METHOD OF MANUFACTURING SEMICONDUCTOR DEVICE, AND SEMICONDUCTOR DEVICE FUJITSU LIMITED (JP) 2010-01-14 US disclosed
EP-2128897-A1 SILICON DIELECTRIC TREATING AGENT FOR USE AFTER ETCHING, PROCESS FOR PRODUCING SEMICONDUCTOR DEVICE, AND SEMICONDUCTOR DEVICE Fujitsu Limited (JP) 2009-12-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100134052-A1 Light Emitting Polymer Devices Using Self-Assembled Monolayer Structures CLTB, CYBA, CLTA LPL 2810/4885LIPG 2004/4885ALDH1A1 1668/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.